Literature DB >> 12791743

Opportunistic screening for Chlamydia at a community based contraceptive service for young people.

V Moens1, G Baruch, P Fearon.   

Abstract

PROBLEM: The suspected high prevalence of Chlamydia infection that is undiagnosed and untreated among high risk women who attend a contraceptive service for young people.
DESIGN: Cross sectional study from a community screening service. BACKGROUND AND
SETTING: An inner city contraceptive and psychotherapy service for young people aged 12-21 years. KEY MEASURE FOR IMPROVEMENT: Prevalence of infection commensurate with or above findings from the national screening pilot (13.8% for > 16 year olds, 10.5% for 16-19 year olds, and 7.2% for 20 to 24 year olds). STRATEGIES FOR CHANGE: Offering testing (of a first catch urine sample) for Chlamydia to all young people using the contraceptive service who were not previously screened; launching a publicity campaign about the new service; training medical staff and reception staff to deliver the service to maximise take up of screening and of treatment by infected cases; and surveying results from testing to monitor significant patterns of infection requiring further action. EFFECTS OF CHANGE: Percentage of clients with infection exceeded targets for each age group, 76% with a positive or equivocal result returned for treatment, 87% of those treated returned for a test of cure, and 99% of tests of cure were negative. Prevention work was initiated in a school with a particularly heavy concentration of infected clients. LESSONS LEARNT: A contraceptive service for young women is a highly acceptable location for effective Chlamydia screening.

Entities:  

Mesh:

Year:  2003        PMID: 12791743      PMCID: PMC1126124          DOI: 10.1136/bmj.326.7401.1252

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  2 in total

1.  Development of programmes for enhancing sexual health.

Authors:  R J DiClemente
Journal:  Lancet       Date:  2001-12-01       Impact factor: 79.321

2.  Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection.

Authors:  K A Fenton; C Korovessis; A M Johnson; A McCadden; S McManus; K Wellings; C H Mercer; C Carder; A J Copas; K Nanchahal; W Macdowall; G Ridgway; J Field; B Erens
Journal:  Lancet       Date:  2001-12-01       Impact factor: 79.321

  2 in total
  4 in total

1.  Opportunistic screening for Chlamydia: Microbiological input is essential in Chlamydia screening programmes.

Authors:  C Y William Tong; Helen Dunn; David A Lewis
Journal:  BMJ       Date:  2003-08-02

2.  Comparing urine samples and cervical swabs for Chlamydia testing in a female population by means of Strand Displacement Assay (SDA).

Authors:  Siren Haugland; Turid Thune; Beata Fosse; Tore Wentzel-Larsen; Stig Ove Hjelmevoll; Helge Myrmel
Journal:  BMC Womens Health       Date:  2010-03-25       Impact factor: 2.809

3.  The prevalence of chlamydial infection in Estonia: a population-based survey.

Authors:  A Uusküla; M Kals; K Denks; Uk Nurm; L Kasesalu; J Dehovitz; L A McNutt
Journal:  Int J STD AIDS       Date:  2008-07       Impact factor: 1.359

4.  Barriers to opportunistic chlamydia testing in primary care.

Authors:  Cliodna A M McNulty; Elaine Freeman; Jo Bowen; Julia Shefras; Kevin A Fenton
Journal:  Br J Gen Pract       Date:  2004-07       Impact factor: 5.386

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.